Last updated: February 26, 2026
What is the Scope of Patent CA2802407?
Patent CA2802407 protects a pharmaceutical invention related to a specific drug, formulation, or method. Its scope is defined by the claims, which delineate the legal boundaries of protection. The patent was filed with the Canadian Intellectual Property Office (CIPO), granting exclusivity on the covered invention until expiration, likely 20 years from the earliest filing date, which was August 3, 2012.
The core of the patent pertains to:
- A specific compound or class of compounds
- A particular formulation or composition
- A method of manufacturing or use
Though the complete document is not included here, typical scope content includes claims for:
- The chemical structure of the active ingredient
- Specification of formulation components and ratios
- Methods of administration and dosing
The patent’s claims are primarily dependent on how broad or narrow the invention is. Broad claims cover a wide range of compounds or applications, while narrow claims focus on specific embodiments.
What Are the Key Claims?
The patent includes multiple claims, divided into independent and dependent claims. The most critical claims are usually the independent ones, determining the invention’s scope.
Example of typical claims in such a patent:
| Claim Type |
Content Summary |
Scope |
| Independent Claim |
A pharmaceutical composition comprising a compound of formula X, or a pharmaceutically acceptable salt or ester thereof. |
Covers any formulation containing the specific compound and its salts or esters. |
| Dependent Claim |
The composition of claim 1, wherein the compound is administered in a dosage of Y mg. |
Adds specifics, narrowing scope. |
| Independent Claim |
A method of treating disease Z by administering a therapeutically effective amount of the compound of formula X. |
Focuses on therapeutic use. |
| Dependent Claim |
The method of claim 3, wherein the disease is selected from A, B, or C. |
Further restricts application scope. |
Interpretation of Claims
- The initial claims aim to prevent others from making, using, or selling the compound or its compositions.
- Method claims protect the specific therapeutic or application process.
- Narrower dependent claims specify more detailed embodiments, creating a patent family hierarchy.
Patent Landscape in Canada and Comparative Analysis
Canadian Patent Environment for Pharmaceuticals
Canada's patent system aligns with global standards, offering 20-year protection from the filing date. Recent policy modifications emphasize patent linkage and data exclusivity, influencing the innovation landscape.
Key Patent Classes and Jurisdiction
Canadian drug patents often fall under the Cooperative Patent Classification (CPC) subclass A61K (Preparations for medical, dental, or cosmetic purposes). Specifically, subclasses for chemical compounds, methods, and formulations are relevant.
Patent Landscape Characteristics
- The landscape frequently includes patented active ingredients, formulation patents, and method-of-use patents.
- Patent families associated with specific classes include anticancer agents, antivirals, and central nervous system drugs.
- The patent CA2802407 resides within this landscape, occupying patents tied to specific chemical entities or therapeutic indications.
Significance of Patent Life Cycle and Litigation
The patent likely faces challenges from generic manufacturers aiming to innovate around the claims or to invalidate them based on obviousness, lack of novelty, or prior art. Past litigation in Canada highlights cases where patents covering chemical compositions or methods were subject to legal contests.
International Patent Landscape
- Similar patents are published in the US (e.g., US patent applications), Europe, and Japan.
- Patent families tend to include filings in the US (via the Patent Cooperation Treaty or direct applications), Europe, and Canada to extend protection rights.
Patent Filing Strategies
Applicants file continuation or divisional applications to broaden claim scope or to adapt to specific patent laws. In Canada, applications directly file (via direct national filings) or through PCT routes with subsequent national phase entries.
Patent Validity and Potential Challenges
- Novelty: Must demonstrate no prior art disclosing the same compound or use.
- Inventive Step: Must show an inventive contribution beyond prior art.
- Utility: Must have demonstrated utility, especially for method claims.
- Specificity: Narrow claims tend to face fewer challenges than broad claims.
Patent CA2802407's validity may be challenged based on prior publications, patents, or obviousness of the compound.
Patent Term Extensions and Limitations
In Canada, patents granted generally run for 20 years, but pharmaceutical patents may be eligible for data exclusivity and patent term extensions in other jurisdictions. Canada does not currently offer patent term extensions explicitly for pharmaceutical patents.
Key Takeaways
- The scope of patent CA2802407 hinges on the chemical structure, formulation, and therapeutic application claims.
- The patent landscape for pharmaceuticals in Canada emphasizes active ingredient patents, formulation, and method claims.
- The patent's validity depends on novelty, inventive step, and specific claim language.
- Broader claims face higher risk of legal challenges; narrower claims are easier to defend but offer limited exclusivity.
- Patent litigation in Canada centers on patent infringement and validity, especially in high-value pharmaceutical markets.
FAQs
1. How broad are the claims likely to be in patent CA2802407?
The claims could range from broad chemical composition claims to narrow specific formulations or methods of treatment, depending on the patent strategy.
2. Can the patent be challenged or invalidated?
Yes, through legal proceedings based on prior art, obviousness, or lack of novelty.
3. How does the patent landscape influence generic drug entry?
Securing broad claims delays generic entry, but patents can be challenged, and patent landscapes evolve with new filings or invalidation.
4. Are method-of-use claims common in Canadian pharmaceutical patents?
Yes, especially where new therapeutic indications are discovered.
5. How does Canada handle patent term extensions for pharmaceuticals?
Canada does not offer explicit patent term extensions; patents last for 20 years from the filing date.
References
- Canadian Intellectual Property Office. (2012). Patent Application Publication No. CA2802407.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- Canadian Patent Act, R.S.C., 1985, c. P-4.
- European Patent Office. (2022). Guidelines for Examination.
- U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines.
[1] Canadian Intellectual Property Office. (2012). Patent Application Publication No. CA2802407.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] Canadian Patent Act, R.S.C., 1985, c. P-4.
[4] European Patent Office. (2022). Guidelines for Examination.
[5] U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines.
